GlassScriptPhysician profile
Wilbert Maniego
NPI 1356392427
$17,299.41
in general payments reported to CMS, 2019-2025
64 companies · $3,864 in 2025
The $3,864 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,385 · 2020: $713 · 2021: $1,713 · 2022: $2,725 · 2023: $2,653 · 2024: $3,248 · 2025: $3,864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,590 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,590.04 |
| Education | $173.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,987.58 | 2019-2025 | Repatha, Evenity, Otezla |
| Astrazeneca Pharmaceuticals LP | $1,553.16 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,246.76 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Sanofi-Aventis U.S. LLC | $1,107.96 | 2019-2025 | |
| Novo Nordisk INC | $1,015.18 | 2019-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $944.27 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $833.71 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Janssen Pharmaceuticals, INC | $788.25 | 2019-2024 | Xarelto |
| Astellas Pharma US INC | $736.08 | 2019-2025 | Veozah, Myrbetriq |
| Abbott Laboratories | $722.37 | 2019-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $693.25 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $468.78 | 2019-2025 | Xifaxan, Trulance, Cycloset |
| Exact Sciences Corporation | $467.03 | 2023-2025 | Cologuard Collection Kit |
| Intuity Medical INC | $435.61 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Pfizer INC. | $428.61 | 2019-2025 |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $427.36 | 2023-2025 | Cequr Simplicity |
| Merck Sharp & Dohme LLC | $371.89 | 2019-2024 | Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $364.28 | 2021-2025 | |
| Abbvie INC. | $342.94 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $294.92 | 2021-2025 | Unithroid |
| Edwards Lifesciences Corporation | $190.19 | 2022-2024 | |
| Amarin Pharma, INC. | $184.58 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $181.45 | 2021-2025 | Gvoke Hypopen |
| Vifor Pharma, INC. | $143.64 | 2022-2025 | Veltassa |
| Sanofi Pasteur INC. | $115.20 | 2019-2025 | |
| Esperion Therapeutics, INC. | $85.06 | 2021-2025 | Nexletol |
| Hikma Pharmaceuticals USA | $83.37 | 2022 | |
| Insmed, INC. | $80.59 | 2024-2025 | Brinsupri, Arikayce |
| Ironwood Pharmaceuticals, INC | $57.20 | 2019-2021 | |
| Eisai INC. | $56.71 | 2024-2025 | |
| Dexcom, INC. | $49.39 | 2021 | |
| Acadia Pharmaceuticals INC | $47.21 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $47.14 | 2023-2025 | Gemtesa |
| Renalytix Ai, INC. | $46.14 | 2023-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Ibsa Pharma INC. | $45.04 | 2022-2023 | Tirosint, Licart |
| Shield Therapeutics INC | $43.69 | 2023 | Accrufer |
| Medtronic, INC. | $40.95 | 2022 | |
| Corcept Therapeutics | $39.52 | 2023 | Korlym |
| Medicomp INC | $37.71 | 2025 | Telepatch Cardiac Monitor |
| Corium, LLC | $35.51 | 2022 | |
| Daiichi Sankyo INC. | $29.14 | 2022 | |
| Smith+Nephew, INC. | $28.96 | 2019 | |
| Genentech USA, INC. | $26.46 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $25.87 | 2024 | Voquezna |
| Neurocrine Biosciences, INC. | $24.98 | 2025 | |
| Scpharmaceuticals INC. | $22.64 | 2025 | |
| Lundbeck LLC | $21.04 | 2023 | Rexulti |
| Avanir Pharmaceuticals, INC. | $20.08 | 2019 | |
| Avvisto Therapeutics, LLC | $20.00 | 2024 | Cycloset |
| Lifescan, INC. | $19.85 | 2023 | |
| Phadia US INC. | $19.72 | 2023 | Immunocap |
| Scilex Pharmaceuticals INC. | $19.40 | 2023 | Ztlido |
| Philips North America LLC | $18.45 | 2021 | |
| Mannkind Corporation | $18.33 | 2021 | |
| Biogen, INC. | $16.23 | 2021 | |
| Althera Pharmaceuticals LLC | $15.71 | 2021 | |
| Alfasigma USA, INC. | $15.36 | 2021 | |
| Ionis Pharmaceuticals, INC. | $15.22 | 2025 | Tryngolza |
| Redhill Biopharma INC. | $14.28 | 2020 | |
| Seqirus USA INC | $14.10 | 2022 | |
| Medicure Pharma INC. | $13.97 | 2025 | Zypitamag |
| Metacel Pharmaceuticals LLC | $13.52 | 2022 | |
| Allergan, INC. | $12.95 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilbert Maniego listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.